- Contracts signed for Murrumbidgee LHD continued use of Miya Precision and Miya MEMRe
- COVID-19 and out-of-hospital monitoring capabilities incorporated into the solution
- Miya MEMRe to be rolled out to up to an additional 200 doctors
- Total contract value of $686k for 12 months from Jan 2020
Alcidion Group Limited (ASX: ALC) is pleased to announce it has signed two contracts with Murrumbidgee Local Health District (LHD) to continue use of Alcidion’s Miya Precision platform, including the MEMRe mobile application and for related professional services.
Earlier this year, Murrumbidgee LHD elected to use Miya Precision for a period of 12 months from 1 January 2020. Their intention to do so was announced to the ASX in April and the value of purchase orders received to that date were included as part of our reported quarterly total of new sold work. Two contracts with a combined total contract value of $686K, confirming the scope of intended use at Wagga Wagga Base Hospital and an extended scope of professional services for this initial 12 months have now been signed.
The confirmed contracted scope of initial deployment includes implementing a COVID-19 monitoring dashboard for Miya Precision, designed to enable the monitoring of COVID-19 positive, and at-risk patients, both in-hospital and remotely. Miya MEMRe will also be rolled out to up to 200 clinicians, which will reduce the risk of infection from using shared devices.
Miya MEMRe is Alcidion’s mobile EMR solution which provides easy access to critical test results and risk indicators in real-time, via mobile devices, to enhance clinical decision-making.
Kate Quirke, Managing Director of Alcidion said, “We are delighted that Murrumbidgee LHD has elected to use Miya Precision and MEMRe. Furthermore, we are pleased to work with the team at Murrumbidgee LHD to further develop the COVID-19 monitoring solution to meet their needs as they utilise vital resources to manage the impact of this ongoing situation.”